WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012041898) COMBINATION OF SGLT2 INHIBITOR AND A SUGAR COMPOUND FOR THE TREATMENT OF DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/041898    International Application No.:    PCT/EP2011/066848
Publication Date: 05.04.2012 International Filing Date: 28.09.2011
IPC:
A61K 31/70 (2006.01), A61K 45/06 (2006.01), A61P 3/10 (2006.01), A61P 13/00 (2006.01)
Applicants: CELON PHARMA SP. Z O.O. [PL/PL]; ul. Ogrodowa 2A PL-05-092 Łomianki/Kiełpin (PL) (For All Designated States Except US).
MACH, Mateusz [PL/PL]; (PL) (For US Only).
GUZENDA, Piotr [PL/PL]; (PL) (For US Only).
WIECZOREK, Maciej [PL/PL]; (PL) (For US Only).
LAMPARSKA-PRZYBYSZ, Monika [PL/PL]; (PL) (For US Only)
Inventors: MACH, Mateusz; (PL).
GUZENDA, Piotr; (PL).
WIECZOREK, Maciej; (PL).
LAMPARSKA-PRZYBYSZ, Monika; (PL)
Agent: SITKOWSKA, Jadwiga; Al. Komisji Edukacji Narodowej 83/106 PL-02-777 Warszawa (PL)
Priority Data:
PL392536 29.09.2010 PL
Title (EN) COMBINATION OF SGLT2 INHIBITOR AND A SUGAR COMPOUND FOR THE TREATMENT OF DIABETES
(FR) COMBINAISON DE L'INHIBITEUR DE SGLT2 ET D'UN COMPOSÉ DE SUCRE POUR LE TRAITEMENT DU DIABÈTE
Abstract: front page image
(EN)The combination of anti-diabetic compound - SGLT2 inhibitor and a sugar compound exhibiting affinity to bacterial lectins. The combination finds the use as a medicament for treating type 2 diabetes with concurrent prevention or treatment of urinary tract or genital organs infections.
(FR)Selon l'invention, la combinaison d'un composé antidiabétique, l'inhibiteur de SGLT2, et d'un composé de sucre présentant une affinité avec des lectines bactériennes peut être utilisée comme médicament pour le traitement du diabète de type 2 avec prévention ou traitement simultané d'infections des voies urinaires ou des organes génitaux.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)